Author response: Migraine monoclonal antibodies against CGRP change brain activity depending on ligand or receptor target – an fMRI study
Hauke Basedau(Universität Hamburg), Arne May(Universität Hamburg), Kuan‐Po Peng(Universität Hamburg), Lisa-Marie Sturm(Universität Hamburg), Jan Mehnert(Universität Hamburg), Marlene Schellong(Universität Hamburg)
Cited by 0
Related Papers
Cluster headache
|Nature Reviews Disease Primers|2018|203
Migraine understood as a sensory threshold disease
|Pain|2019|130
Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: A clinic-based study in Taiwan
|Cephalalgia|2012|88
Migraine and incidence of ischemic stroke: A nationwide population-based study
|Cephalalgia|2016|86
Epidemiology of Headache Disorders in the <scp>A</scp> sia‐ <scp>P</scp> acific Region
|Headache The Journal of Head and Face Pain|2014|78